The Effectiveness of a Care Bundle to Prevent Postpartum Hemorrhage After Cesarean Delivery

Launched by DUNJIN CHEN · Nov 11, 2024

Keywords

ClinConnect Summary

This clinical trial is designed to study how effective a special care plan can be in preventing postpartum hemorrhage (excessive bleeding after childbirth) in women who have a cesarean delivery (a surgical procedure to deliver a baby). The trial will use a group of hospitals that have more than 100 cesarean deliveries each year to see if this comprehensive approach can help detect and treat bleeding more quickly and effectively, which could reduce complications and improve safety for mothers.

To participate in this trial, women must be having a cesarean delivery at a public hospital and be willing to sign a consent form that explains the study. However, if a hospital cannot provide certain data, or if a woman does not have blood test results from the two weeks before her surgery, she will not be eligible. While the trial is not yet recruiting participants, it aims to gather important information that could help improve care for mothers after cesarean deliveries in the future. If you or someone you know is interested, it’s a good idea to keep an eye out for when the trial starts.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Hospital level
• • 1. Public hospitals
• • 2. There are more than 100 cesarean deliveries per year
• • Patient level
• • 1. Cesarean delivery
• • 2. Sign informed consent
• Exclusion Criteria:
• • Hospital level
• • 1. Data verification information cannot be provided
• • Pregnant woman level 1. No blood routine results within 2 weeks before surgery